✦ LIBER ✦

Tau protein and beta-amyloid1-42CSF levels in different phenotypes of Parkinson’s disease

✍ Scribed by Hana Přikrylová Vranová; Jan Mareš; Petr Hluštík; Martin Nevrlý; David Stejskal; Jana Zapletalová; Radko Obereigneru; Petr Kaňovský

Publisher: Springer
Year: 2011
Tongue: English
Weight: 289 KB
Volume: 119
Category: Article
ISSN: 1435-1463
DOI: 10.1007/s00702-011-0708-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Vitreous fluid levels of β-amyloid(1–42)

Vitreous fluid levels of β-amyloid(1–42)and tau in patients with retinal diseases

✍ Shinji Yoneda; Hideaki Hara; Akira Hirata; Mikiko Fukushima; Yasuya Inomata; Hid 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 123 KB

CSF levels of tau, β-amyloid1–42and GAP-

CSF levels of tau, β-amyloid1–42and GAP-43 in frontotemporal dementia, other types of dementia and normal aging

✍ M. Sjögren; L. Minthon; P. Davidsson; A. -K. Granérus; A. Clarberg; H. Vandersti 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 155 KB

CSF-tau, CSF-Aß1-42, ApoE-genotype and c

CSF-tau, CSF-Aß1-42, ApoE-genotype and clinical parameters in the diagnosis of Alzheimer’s disease: combination of CSF-tau and MMSE yields highest sensitivity and specificity

✍ S. Ganzer; S. Arlt; V. Schoder; C. Buhmann; E.-M. Mandelkow; U. Finckh; U. Beisi 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 226 KB

Inverse association of cortisol serum le

Inverse association of cortisol serum levels with T-tau, P-tau 181 and P-tau 231 peptide levels and T-tau/Aβ 1–42 ratios in CSF in patients with mild Alzheimer’s disease dementia

✍ Christoph Laske; Elke Stransky; Andreas Fritsche; Gerhard W. Eschweiler; Thomas 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 229 KB

Combined analysis of CSF βA42 peptide an

Combined analysis of CSF βA42 peptide and tau protein and serum antibodies to glycosaminoglycans in Alzheimer's disease: preliminary data

✍ C. Briani; S. Ruggero; M. Naccarato; A. Cagnin; G. L. Ricchieri; L. Pasqui; G. P 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 50 KB

The diagnostic value of tau protein, β-a

The diagnostic value of tau protein, β-amyloid (1–42) and their ratio for the discrimination of alcohol-related cognitive disorders from Alzheimer's disease in the early stages

✍ Elisabeth Kapaki; Ioannis Liappas; George P. Paraskevas; Ilia Theotoka; Andreas 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB 👁 1 views

Background Chronic and heavy alcohol abuse or dependence may result in impaired cognition and dementia. The increased risk of Alzheimer's disease (AD) in older individuals interferes with the differential diagnosis, especially when dealing with elderly patients with a long history of alcohol abuse.